Aller au contenu

Publications scientifiques

  • article Vachon K, Tardif MA, Paillé É and Leblanc MH, Cantin G, Lemieux C, Gallagher G

    Determining the best premedication regimen to prevent rabbit anti-human thymocyte globulin infusion-associated reactions: A retrospective study comparing two hematopoietic stem …

    Transpl Immunol 89 2025.

    DOI PUBMED
  • article Pelland AA, Deschênes-Simard X, Savard X, Giguère P, Spillane D, Barabé F, Laroche V, Munger M, Gallagher G, Marcoux N, Cantin G, Chénard-Poirier M, Delage R, Lalancette M, Veilleux O, Assouline SE, Lemieux C

    Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study

    Leuk Lymphoma 65 (13), 2024.

    DOI PUBMED
  • article Leblanc D, Cantin G, Desnoyers A, Dufresne J, Masucci GL, Panet-Raymond V, Poirier É and Soldera S, Gingras I

    Management of Oligometastatic Breast Cancer: An Expert Committee’s Opinion

    Curr Oncol 30 (2), 2023.

    DOI PUBMED
  • article Lemieux J, Forget G, Brochu O, Provencher L, Cantin G, Desbiens C, Doyle C, Poirier B, Camden S, Durocher M

    Evaluation of eligibility and recruitment in breast cancer clinical trials

    Breast 23 (4), 2014.

    DOI PUBMED
  • article Poirier E, Desbiens C, Poirier B, Hogue JC, Lemieux J, Doyle C, Leblond AF, Cote I, Cantin G, Provencher L

    Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients

    Ann Pharmacother 48 (4), 2014.

    DOI PUBMED